Reliability of C-reactive protein as a predictor of early neurological deficit in acute ischemic stroke: is it only to be blamed? a retrospective observational study

Vikasdeep Bansal, Komal Agrawal


Background: Ischemic Stroke is a common cause of morbidity and mortality. Various parameters, both clinical and laboratory have been studied as markers of Early Neurological Deterioration (END) out of which CRP has been the most important. This retrospective study of ours is an attempt to study its influence on END by minimizing other variables as much as possible.

Methods: 50 patients were chosen retrospectively strictly according to laid down inclusion and exclusion criteria, their data recorded and analyzed with 17.0 SPSS software. Any p value <0.05 was taken as significant.

Results: Significantly raised CRP values were found in elderly patients (p=0.0001) and in males (p=0.003). Higher incidences of ENDs were also found in elderly patients (p=0.326) and males (p=0.846) and patients with raised CRP levels (p=0.057).

Conclusions: Higher Values of CRP are associated with increased frequency of ENDs. But in patients with multiple factors which can influence both CRP and END, CRP alone should not be thought of as the only culprit.


C-reactive protein level, Early neurological deterioration, High sensitivity CRP, National institute of health stroke scale

Full Text:



Lakhan SE, Kirchgessner A, Hofer M. Inflammatory mechanisms in ischemic stroke: therapeutic approaches. J Trans Med. 2009 Dec;7(1):97.

Lo EH, Dalkara T, Moskowitz MA. Mechanisms, challenges and opportunities in stroke. Nature Revi Neurosci. 2003 May;4(5):399-414.

Schmidt A, Hoppen M, Strecker JK, Diederich K, Schäbitz WR, Schilling M, Minnerup J. Photochemically induced ischemic stroke in rats. Exp Transl Stroke Med 4: 13.

Irimie CA, Vârciu M, Irimie M, Ifteni PI, Minea DI. C-Reactive Protein and T3: New Prognostic Factors in Acute Ischemic Stroke. J Stroke Cerebro Dis. 2018 Oct 1;27(10):2731-7.

Dewan KR, Rana PV. C–reactive protein and early mortality in acute ischemic stroke. Kathmandu Uni Med J. 2011;9(4):252-5.

Wityk RJ, Pessin MS, Kaplan RF, Caplan LR. Serial assessment of acute stroke using the NIH Stroke Scale. Stroke. 1994 Feb;25(2):362-5.

Toni D, Fiorelli M, Gentile M, Bastianello S, Sacchetti ML, Argentino C, et al. Progressing neurological deficit secondary to acute ischemic stroke: a study on predictability, pathogenesis, and prognosis. Archiv Neurol. 1995 Jul 1;52(7):670-5.

Kwon HM, Lim JS, Park HK, Lee YS. Hypertriglyceridemia as a possible predictor of early neurological deterioration in acute lacunar stroke. J Neurol Sci. 2011 Oct 15;309(1-2):128-30.

Ischemic stroke patients independent of inflammatory mediators: a hospital-based prospective study. Oxid Med Cell Longev. 2016;2016:8346301.

Zhang X, Sun Z, Ding C, Tang Y, Jiang X, Xie Y, et al. Metabolic syndrome augments the risk of early neurological deterioration in acute ischemic stroke patients independent of inflammatory mediators: a hospital-based prospective study. Oxid Med Cellular Longe. 2016;2016.

Kim YD, Song D, Kim EH, Lee KJ, Lee HS, Nam CM, et al. Long-term mortality according to the characteristics of early neurological deterioration in ischemic stroke patients. Yonsei Med J. 2014 May 1;55(3):669-75.

Kim JT, Heo SH, Yoon W, Choi KH, Park MS, Saver JL, et al. Clinical outcomes of patients with acute minor stroke receiving rescue IA therapy following early neurological deterioration. J Neurointerv Surg. 2016 May 1;8(5):461-5.

Kwon HM, Lee YS, Bae HJ, Kang DW. Homocysteine as a predictor of early neurological deterioration in acute ischemic stroke. Stroke. 2014 Mar;45(3):871-3.

Ferrari J, Knoflach M, Kiechl S, Willeit J, Schnabl S, Seyfang L, et al. Early clinical worsening in patients with TIA or minor stroke: the Austrian Stroke Unit Registry. Neurology. 2010 Jan 12;74(2):136-41.

Thanvi B, Treadwell S, Robinson T. Early neurological deterioration in acute ischaemic stroke: predictors, mechanisms and management. Postgrad Med J. 2008 Aug 1;84(994):412-7.

Rödén-Jüllig Å. Progressing stroke: epidemiology. Cerebro Dis. 1997;7(Suppl. 5):2-5.

Dávalos A, Toni D, Iweins F, Lesaffre E, Bastianello S, Castillo J. Neurological deterioration in acute ischemic stroke: potential predictors and associated factors in the European cooperative acute stroke study (ECASS) I. Stroke. 1999 Dec;30(12):2631-6.

Roquer J, Rodríguez-Campello A, Gomis M, Jiménez-Conde J, Cuadrado-Godia E, Vivanco R, et al. Acute stroke unit care and early neurological deterioration in ischemic stroke. J Neurol. 2008 Jul 1;255(7):1012-7.

Kim JP, Kim SJ, Lee JJ, Cha JH, Bang OY, Chung CS, et al. Diffusion-perfusion mismatch in single subcortical infarction: a predictor of early neurological deterioration and poor functional outcome. Eur Neurol. 2015;73(5-6):353-9.

Siegler JE, Boehme AK, Kumar AD, Gillette MA, Albright KC, Martin-Schild S. What change in the National Institutes of Health Stroke Scale should define neurologic deterioration in acute ischemic stroke?. J Stroke Cerebro Dis. 2013 Jul 1;22(5):675-82.

Abubakar SA, Okubadejo NU, Ojo OO, Oladipo O, Ojini FI, Danesi MA. Relationship between admission serum C-reactive protein and short term outcome following acute ischaemic stroke at a tertiary health institution in Nigeria. Niger J Clin Prac. 2013;16(3):320-4.

Di Napoli M, Papa F, Bocola V. C-reactive protein in ischemic stroke: an independent prognostic factor. Stroke. 2001 Apr;32(4):917-24.

Seo WK, Seok HY, Kim JH, Park MH, Yu SW, Oh K, et al. C-reactive protein is a predictor of early neurologic deterioration in acute ischemic stroke. J Stroke Cerebro Dis. 2012 Apr 1;21(3):181-6.

Moon AR, Choi DH, Jahng SY, Kim BB, Seo HJ, Kim SH, et al. High-sensitivity C-reactive protein and mean platelet volume as predictive values after percutaneous coronary intervention for long-term clinical outcomes: a comparable and additive study. Blood Coagul Fibrin. 2016 Jan 1;27(1):70-6.

Jiménez MC, Rexrode KM, Glynn RJ, Ridker PM, Gaziano JM, Sesso HD. Association between high‐sensitivity C‐Reactive protein and total stroke by hypertensive status among men. J Am Heart Assoc. 2015 Sep 21;4(9):e002073.

Heidari B, Heidari P, TAYEBI ME. The value of changes in CRP and ESR for predicting treatment response in rheumatoid arthritis. APLAR J Rheumatol. 2007 Apr;10(1):23-8.

Heidari B, Fazli MR, Misaeid MA, Heidari P, Hakimi N, Zeraati AA. A linear relationship between serum high-sensitive C-reactive protein and hemoglobin in hemodialysis patients. Clin Exper Nephrol. 2015 Aug 1;19(4):725-31.

Hajian-Tilaki K, Heidari B, Firouzjahi A, Bagherzadeh M, Hajian-Tilaki A, Halalkhor S. Prevalence of metabolic syndrome and the association with socio-demographic characteristics and physical activity in urban population of Iranian adults: a population-based study. Diabe Metab Synd: Clin Res Rev. 2014 Jul 1;8(3):170-6.

Firouzjahi A, Monadi M, Karimpoor F, Heidari B, Dankoob Y, Hajian-Tilaki K, et al. Serum C-reactive protein level and distribution in chronic obstructive pulmonary disease versus healthy controls: a case–control study from Iran. Inflammation. 2013 Oct 1;36(5):1122-8.